Observe Medical ASA (OSL:OBSRV)
Norway · Delayed Price · Currency is NOK 0.6400
+0.0150 (2.40%)
At close: Nov 12, 2025
Observe Medical ASA Revenue
Observe Medical ASA had revenue of 11.33M NOK in the half year ending June 30, 2025, a decrease of -4.16%. This brings the company's revenue in the last twelve months to 17.83M, down -36.55% year-over-year. In the year 2024, Observe Medical ASA had annual revenue of 18.48M, down -33.85%.
Revenue (ttm)
17.83M
Revenue Growth
-36.55%
P/S Ratio
4.89
Revenue / Employee
4.46M
Employees
5
Market Cap
87.13M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 18.48M | -9.46M | -33.85% |
| Dec 31, 2023 | 27.94M | 8.42M | 43.14% |
| Dec 31, 2022 | 19.52M | -4.52M | -18.80% |
| Dec 31, 2021 | 24.04M | 21.08M | 711.96% |
| Dec 31, 2020 | 2.96M | 2.78M | 1,572.88% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Medistim ASA | 662.18M |
| Nordhealth AS | 589.78M |
| Navamedic ASA | 539.42M |
| Photocure ASA | 537.59M |
| Omda AS | 458.96M |
| Vistin Pharma ASA | 455.25M |
| Gentian Diagnostics ASA | 172.52M |
| ArcticZymes Technologies ASA | 109.99M |